Review



computerized cognitive composite (c3)  (Florey Institute of Neuroscience and Mental Health)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Florey Institute of Neuroscience and Mental Health computerized cognitive composite (c3)
    Computerized Cognitive Composite (C3), supplied by Florey Institute of Neuroscience and Mental Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computerized+cognitive+composite+%28c3%29/10__1016_slash_j__jalz__2018__07__162-81-2-64?v=Florey+Institute+of+Neuroscience+and+Mental+Health
    Average 90 stars, based on 1 article reviews
    computerized cognitive composite (c3) - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    c3 (computerized cognitive composite)  (CogState Ltd)
    90
    CogState Ltd c3 (computerized cognitive composite)
    Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment
    C3 (Computerized Cognitive Composite), supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computerized+cognitive+composite+%28c3%29/pmc08290833-103-9-5?v=CogState+Ltd
    Average 90 stars, based on 1 article reviews
    c3 (computerized cognitive composite) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    computerized cognitive composite (c3)  (CogState Ltd)
    90
    CogState Ltd computerized cognitive composite (c3)
    Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment
    Computerized Cognitive Composite (C3), supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computerized+cognitive+composite+%28c3%29/pmc07784542-65-3-9?v=CogState+Ltd
    Average 90 stars, based on 1 article reviews
    computerized cognitive composite (c3) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    computerized cognitive composite (c3) battery  (CogState Ltd)
    90
    CogState Ltd computerized cognitive composite (c3) battery
    Participant characteristics and cognitive performance
    Computerized Cognitive Composite (C3) Battery, supplied by CogState Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computerized+cognitive+composite+%28c3%29/pmc05726304-100-14-13?v=CogState+Ltd
    Average 90 stars, based on 1 article reviews
    computerized cognitive composite (c3) battery - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    computerized cognitive composite (c3)  (Florey Institute of Neuroscience and Mental Health)
    90
    Florey Institute of Neuroscience and Mental Health computerized cognitive composite (c3)
    Participant characteristics and cognitive performance
    Computerized Cognitive Composite (C3), supplied by Florey Institute of Neuroscience and Mental Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/computerized+cognitive+composite+%28c3%29/10__1016_slash_j__jalz__2018__07__162-81-2-64?v=Florey+Institute+of+Neuroscience+and+Mental+Health
    Average 90 stars, based on 1 article reviews
    computerized cognitive composite (c3) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment

    Journal: Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

    Article Title: Current advances in digital cognitive assessment for preclinical Alzheimer's disease

    doi: 10.1002/dad2.12217

    Figure Lengend Snippet: Validation of primarily in‐clinic computerized and tablet‐based cognitive assessment

    Article Snippet: A more recent iteration of Cogstate tasks is the C3 (Computerized Cognitive Composite) which includes the CBB in addition to two measures potentially sensitive to changes in early AD based on evidence from the cognitive neuroscience literature: the Behavioral Pattern Separation–Object Version (BPS‐O) and The Face‐Name Associative Memory Test (FNAME).

    Techniques: Biomarker Discovery

    Participant characteristics and cognitive performance

    Journal: The journal of prevention of Alzheimer's disease

    Article Title: Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

    doi: 10.14283/jpad.2017.1

    Figure Lengend Snippet: Participant characteristics and cognitive performance

    Article Snippet: Two computerized batteries that are of particular relevance to these questions are the Cogstate Computerized Cognitive Composite (C3) battery ( 1 ), which is currently being used in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) secondary prevention trial ( 9 ), and the newly developed, non-proprietary iPad version of the National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) (for reference to the general computerized battery: 14, 15).

    Techniques:

    Regression and ROC analyses with each computerized composite to predict subtle cognitive impairment or typical performance on the PACC

    Journal: The journal of prevention of Alzheimer's disease

    Article Title: Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

    doi: 10.14283/jpad.2017.1

    Figure Lengend Snippet: Regression and ROC analyses with each computerized composite to predict subtle cognitive impairment or typical performance on the PACC

    Article Snippet: Two computerized batteries that are of particular relevance to these questions are the Cogstate Computerized Cognitive Composite (C3) battery ( 1 ), which is currently being used in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) secondary prevention trial ( 9 ), and the newly developed, non-proprietary iPad version of the National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) (for reference to the general computerized battery: 14, 15).

    Techniques:

    Scatterplot of association between NIHTB-CB and Cogstate C3 battery, with slopes estimating group effect of high and low PACC performance

    Journal: The journal of prevention of Alzheimer's disease

    Article Title: Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

    doi: 10.14283/jpad.2017.1

    Figure Lengend Snippet: Scatterplot of association between NIHTB-CB and Cogstate C3 battery, with slopes estimating group effect of high and low PACC performance

    Article Snippet: Two computerized batteries that are of particular relevance to these questions are the Cogstate Computerized Cognitive Composite (C3) battery ( 1 ), which is currently being used in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) secondary prevention trial ( 9 ), and the newly developed, non-proprietary iPad version of the National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) (for reference to the general computerized battery: 14, 15).

    Techniques: Battery

    ROCs for the NIHTB-CB and Cogstate C3 composites, and the C3 FNLT task alone to distinguish between high and low PACC performance (Blue = C3 Learning-Memory, Red = NIHTB-CB, Green = C3 Processing Speed-Attention, Grey = C3 FNLT, Black-dash = NIH PSMT)

    Journal: The journal of prevention of Alzheimer's disease

    Article Title: Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

    doi: 10.14283/jpad.2017.1

    Figure Lengend Snippet: ROCs for the NIHTB-CB and Cogstate C3 composites, and the C3 FNLT task alone to distinguish between high and low PACC performance (Blue = C3 Learning-Memory, Red = NIHTB-CB, Green = C3 Processing Speed-Attention, Grey = C3 FNLT, Black-dash = NIH PSMT)

    Article Snippet: Two computerized batteries that are of particular relevance to these questions are the Cogstate Computerized Cognitive Composite (C3) battery ( 1 ), which is currently being used in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) secondary prevention trial ( 9 ), and the newly developed, non-proprietary iPad version of the National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) (for reference to the general computerized battery: 14, 15).

    Techniques:

    Diagrammatic representation of each composite arising from the Cogstate C3 and NIHTH-CB computerized batteries, and their corresponding tests. Each composite is also attached to an odds ratio (OR) which represents the ability of each composite to distinguish between typical and subtly impaired PACC performance. The pink boxes denote the tasks that were most contributory to the variance explained in the logistic regression model

    Journal: The journal of prevention of Alzheimer's disease

    Article Title: Computerized Cognitive Testing for Use in Clinical Trials: A Comparison of the NIH Toolbox and Cogstate C3 Batteries

    doi: 10.14283/jpad.2017.1

    Figure Lengend Snippet: Diagrammatic representation of each composite arising from the Cogstate C3 and NIHTH-CB computerized batteries, and their corresponding tests. Each composite is also attached to an odds ratio (OR) which represents the ability of each composite to distinguish between typical and subtly impaired PACC performance. The pink boxes denote the tasks that were most contributory to the variance explained in the logistic regression model

    Article Snippet: Two computerized batteries that are of particular relevance to these questions are the Cogstate Computerized Cognitive Composite (C3) battery ( 1 ), which is currently being used in the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) secondary prevention trial ( 9 ), and the newly developed, non-proprietary iPad version of the National Institutes of Health (NIH) Toolbox Cognition Battery (NIHTB-CB) (for reference to the general computerized battery: 14, 15).

    Techniques: